posting velocity //
Posting timing (day/hour) is available only when there are at least 5 jobs with a real publish stamp spread across 3 distinct days. This company's source doesn't expose post times, or there isn't enough data yet — showing what we know for sure: how many jobs are open, in which domains, and at which seniority levels.
Based on 3 events over 24 days. Green days had more opens than closes, red vice-versa. The dark line is the 7-day rolling average.
role mix //
The green layer is the current share of active openings by role. The grey dashed layer is the 90-day baseline — gaps between them show where the company is shifting its hiring mix.
seniority pyramid //
Seniority is not exposed by the source for this company.
Distribution of active openings by seniority. The 'unknown' row groups jobs from sources that don't expose seniority.
geography //
Active openings by region. Click a row to see jobs in that area.
time on market //
Median
6.3 days
25th pct
6.3 days
75th pct
—
Based on 1 closed jobs and 1 still open (right-censored). Curve is Kaplan-Meier; band is the 95% CI.Low event count — the median will stabilise after ~49 more closures. Until then treat the values as indicative.
Window: 180 days back. Don't read the mean — the long tail biases it. Median and percentiles are the honest summary.
Republish rate
—
Fewer than 10 closures in the window — not enough to compute.
Medatech is an implementation partner of Priority Software in Israel. Its client base primarily consists of local industrial, commercial, and service-oriented companies. Direct competitors include other Priority implementers, such as FBC. The majority of Medatech's operations are based in Israel, where it typically hires information systems implementers, industrial engineers, and Priority developers for both in-house development and on-site client deployment.
hiring signal · from our data
From our job data · always current
1 open roles in Israel
Live openings we track — Israel first, plus worldwide when we have them.
news feed
No recent news about this company.